Background. Opioid misuse is a significant public health problem. As initial exposures to opioids are frequently encountered through the management of postoperative pain, we examined patterns of opioid prescribing following surgical treatment for nephrolithiasis. Methods. We identified patients with nephrolithiasis in the national Women Veterans Cohort Study (WVCS) who were treated surgically by diagnosis and procedure codes. Using standard conversion factors, we calculated the morphine milligram equivalent (MME) dose prescribed. We used descriptive statistics to characterize opioid prescription across management strategy and multivariable regression to examine clinical and demographic characteristics associated with dispensed dose. Results. We identified 22,609 patients diagnosed with kidney stones during 1999-2014, 1,976 of whom were treated surgically and 1,582 (80.1%) of whom received an opioid prescription. The median age was 39 years, and 1,366 (90%) were male; 1,314 (86.3%) were treated with ureteroscopy, 172 (11.3%) with extracorporeal shockwave lithotripsy, and 36 (2.4%) with percutaneous nephrolithotomy. The median number of days supplied per opioid prescription (interquartile range) was 10 (5-14), and patients were dispensed a median of 180 (140-300) MME. A total of 6.4% of patients received 50 MME/d. On multivariable analysis, comorbid diagnosis of post-traumatic stress disorder (PTSD) was associated with higher total dispensed dose, whereas surgery type was not. Conclusions. We observed substantial variation in opioid prescribing following surgical treatment of nephrolithiasis. Although type of surgical intervention did not impact opioid dosing, patients with a diagnosis of PTSD were more likely to receive higher doses. This work can inform efforts to improve the safety and efficacy of postoperative opioid prescribing.
Introduction
Opioid-related mortality has risen dramatically in the United States over the past decade, resulting in more than 22,000 deaths in 2015 [1] . A vigorous public health response has been mobilized to address the opioid epidemic, including the development of guidelines by numerous agencies including the Centers for Disease Control and Prevention (CDC) advocating for greater restraint in prescribing practices [2] . Although prescription of opioids in 2018 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
S12
Pain Medicine, 19, 2018, S12-S18 doi: 10.1093/pm/pny125 Original Research Article the postoperative setting accounts for approximately 40% of the national supply, little research has directly addressed short-term prescription accompanying surgical interventions [3, 4] . Recently, growing recognition of the contribution of surgical sources of opioid prescription has emerged, including insights into the variability in prescribing practices and risks for persistent use among opioid-naïve individuals following general and specialty surgery procedures [5] [6] [7] [8] .
The nature of surgical prescribing patterns following urological surgery is undefined, yet it represents a compelling and time-sensitive area for study. As even short-term exposures contribute significantly to the development of long-term use, opioid use disorder and overdose efforts to define best practice standards after urologic surgery and identify the degree of variation observed may offer insights for improving care [9] . Opioid management of kidney stone episodes is particularly important in light of the high incidence, intensity of pain, and recurrent nature of the disease [10] . To better understand the national variation in opioid dispensing practices after kidney stone surgery, we examined postsurgical opioid receipt in a national cohort of Iraq and Afghanistan veterans treated within the Veterans Health Administration (VHA). We hypothesized that a high degree of variation in prescribing patterns exists following surgical treatment for nephrolithiasis, including a substantial proportion of patients receiving doses in excess of defined safety thresholds.
Methods

Study Population
The primary analytic sample consisted of patients within the Women Veterans Cohort Study (WVCS), a cohort of male and female veterans deployed in support of Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn (OEF/OIF/OND). This electronic medical record (EMR) cohort consists of veterans from the OEF/OIF/OND roster and was designed to improve the understanding of longitudinal health care delivery following military service, with an emphasis on female veterans. The roster includes a list of veterans separated from military service who enrolled in the VHA between October 1999 and September 2014 (N ¼ 1.4 million). The cohort includes information regarding sex, race/ethnicity, branch of service, and electronic health record data including inpatient and outpatient health care encounters, medications, laboratory data, and coded procedures (based on Common Procedural Terminology [CPT]) and diagnostic conditions (based on the International Classification of Diseases, Ninth Revision ). It has previously been used extensively to study measures of pain and opioid use in the VHA [11] [12] [13] .
Outcome Measures
We retrospectively identified patients undergoing treatment for kidney stone disease identified by CPT code, cross-referenced with the diagnosis code (ICD-9) between October 1999 and September 2014. Surgeries considered included ureteroscopy with lithotripsy, extracorporeal shockwave lithotripsy (ESWL), and percutaneous nephrolithotomy (PCNL). To evaluate surgical sources of opioid prescription, we excluded patients receiving concurrent long-term opioid therapy at the time of stone procedure, defined as receipt of 90 days of opioids within a 365-day period. In addition, patients receiving long-term therapy with partial opioid agonists (buprenorphine) were excluded, as these exposures may confound standard postoperative opioid dispensing. The primary outcome was total dose dispensed from the pharmacy record, and it was calculated as morphine milligram equivalent (MME) using previously defined methods [14] [15] [16] . We examined additional dosing considerations including total daily doses in excess of 50 MME/d, a high-risk threshold that has previously been defined by the VHA Clinical Practice Guideline and corresponds to 33 mg of oxycodone or 50 mg of hydrocodone daily [17] .
Assessment of Baseline Pain and Related Variables
Prior studies have demonstrated that numerous clinical and demographic factors bear strong associations with receipt of opioid therapy, including substance use history, smoking history, higher baseline pain intensity, and comorbid psychiatric disease [5, 11, 18] . Assessments of baseline pain are included within the WVCS cohort as veterans are screened for the presence of pain using a 0-10 numeric scale routinely during primary care visits, rating pain from 0 ("no pain") to 10 ("worst pain imaginable"). Mental health conditions were included based on ICD-9 codes relating to prevalent diagnoses within veteran populations at any time: alcohol use disorder, substance use (defined as alcohol or drug use disorder), traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), depression (major and minor), and bipolar disorder.
Statistical Analysis
We used descriptive statistics to characterize clinical and demographic characteristics among veterans receiving surgical treatment for kidney stone disease. We described the filled opioid prescriptions including daily MME dispensed, total pill counts, and number of days prescribed using frequency tables and the chi-square test. We examined dispensed opioid quantities following surgery and compared doses by surgery type using t tests. Univariate comparisons of high-dose opioid prescription were performed based on clinical and demographic characteristics. We constructed multivariable linear and logistic regression models to examine factors associated with opioid receipt adjusted for age, sex, race/ethnicity, surgery type, substance use disorder, and psychiatric comorbidity. Two-sided P values <0.05 were considered statistically significant.
Results
We identified 22,609 patients diagnosed with kidney stone disease, of whom 1,976 (8.7%) underwent surgical treatment, including ureteroscopy (84.5%), ESWL (12.6%), or PCNL (2.9%). A total of nine patients on long-term opioids at the time of surgery were excluded, including six (0.3%) who were dispensed opioids postoperatively and three (0.15%) who were not. Of patients receiving surgery, 80.5% (1,582) were prescribed opioids. The median number of days supplied per opioid prescription (IQR) was 10 (5-14) , and the median number of pills dispensed was 30 (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) . Of those receiving opioids, 6.4% of veterans received daily doses in excess of 50 MME. The median daily MME (IQR) was 21.4 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , and total opioid quantity prescribed was 180 MME. A wide dosing distribution was observed as depicted in Figure 1 (IQR ¼ 140-300). Opioid receipt was more common in younger patients, those with diagnosis of TBI, PTSD, or depression, and in patients treated with PCNL (Table 1) . Among individuals receiving opioids, however, total doses were similar among surgical approaches (total MME ¼ 175, 200, and 200 for ureteroscopy, ESWL, and PCNL, respectively, P ¼ 0.46). The median daily dose was similar for ureteroscopy, ESWL, and PCNL (25, 24, and 22.5 MME, respectively, P ¼ 0.79). Moreover, the number of days supplied opioids postoperatively did not differ significantly across surgeries (P ¼ 0.70).
We examined patient clinical and demographic characteristics associated with opioid dose dispensed. In a linear regression model of total MME prescribed, diagnosis of PTSD (P < 0.01) was significantly associated with higher total opioid dose, whereas male sex did not meet the defined statistical threshold (P ¼ 0.063358). Male sex (P ¼ 0.0126) was an independent predictor of greater number of opioid pills dispensed (Table 2 ). In a logistic regression model adjusted for patient age, sex, race/ethnicity, substance use disorder, and surgery type, a prior diagnosis of PTSD was significantly associated with receipt of daily doses greater than 50 MME (odds ratio ¼ 1.77, 95% confidence interval ¼ 1.14-2.74). No associations were noted among patient age, comorbidity, substance use disorder, or type of surgery (Table 3) .
Discussion
Although the vast majority of patients undergoing surgical treatment of kidney stones in the VHA received opioid prescriptions, there was substantial variation across patients in the dose received. Moreover, we observed that male patients and those with a diagnosis of PTSD were significantly more likely to receive any opioid prescription and received higher total doses. A significant minority of patients (6.4%) received doses considered risky for long-term prescribing: >50 MME/d. To our knowledge, this is the first published study addressing variation in opioid prescribing post-urological surgery.
This work builds upon prior evidence in important ways. Contemporary studies have examined surgical prescribing patterns following common general surgery procedures, including cholecystectomy and hernia repair at a single institution, noting wide variation in the prescription of opioids, including a considerable proportion of 
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patients who received doses regarded as high risk [5] . There are comparatively fewer data available regarding national opioid prescription following urological surgery. Among patients administered questionnaires following urological surgery at the University of Utah two to four weeks postoperation, 67% reported surplus medication [19] . In our study examining national-level VHA data, we identified a high degree of variation in surgical opioid prescription after kidney stone surgery, including 6.5% of veterans receiving >50 MME daily, which may help to estimate the prevalence of overprescription.
The risk of subsequent long-term opioid use among opioid-naïve individuals is increased following common surgeries undertaken in the United States, including urological surgery [20, 21] . These do not appear static, with varying degrees of risk conferred by surgery type implying an unmet need to address considerations of postoperative opioid use on an individual basis [21] . In a study examining opioid persistence beyond 90 days after surgery, all interventions were associated with an elevated risk of continued use relative to baseline, including transurethral resection of the prostate (TURP). Moreover, the development of long-term opioid use after surgery appears to be unrelated to the procedure scale ("major" vs "minor"), suggesting that patient-and provider-level factors may contribute significantly to persistent use [6] .
We identified a significant association of a PTSD and higher prescription dosage. These findings are notable given prior studies identifying associations of psychiatric comorbidities with long-term opioid use following common procedures. Prior work addressing patterns of opioid use in Iraq and Afghanistan veterans has shown that patients with PTSD were significantly more likely to receive high doses of opioids, and that being an Iraq or Afghanistan veteran with PTSD was associated with high-risk use and adverse clinical outcomes [22, 23] . Several explanations for why patients with PTSD receive more opioids have been advanced, including evidence that patients with PTSD experience maladaptive coping strategies and beliefs about pain. Additionally, it has been proposed that pain and PTSD share similar pathways, including activation of endogenous opioid neurosignaling pathways that may make patients with PTSD more susceptible to pain [24] .
Associations of mental health diagnoses and opioid receipt have previously been demonstrated after urological surgery. Following surgery for kidney stones, one publication examined rates of "doctor shopping," which was identified in nearly one-quarter of patients after ureteroscopy and was associated with younger age, lower education level, a history of mental illness, and prior history of stone surgery [25] . In addition, a recent study examined the rates of opioid use following urological surgery in the state of California between 2007 and 2011, noting an overall low rate of adverse opioid events (less than one per 1,000), but that opioid dependence or overdose was associated with younger patient age and baseline depression [26] . We observed significant gender differences in opioid prescription, whereby men received higher doses and greater numbers of pills. Although these findings suggest that male patients may be at higher risk for overtreatment, they highlight potential biases in analgesic practices resulting in undertreatment of pain in women. For example, prior studies examining opioid prescription among patients treated in the emergency department with acute abdominal pain demonstrated that, even after controlling for pain score and other clinical factors, women were 13-25% less likely to receive opioid analgesia [27] . In moderating opioid prescription, these results warrant an appreciation for disparities in postoperative pain management that could be worsened for some patients. Considerations of undertreating pain may be particularly relevant in light of a substantial body of evidence supporting an association of uncontrolled pain and adverse surgical outcomes, including impaired wound healing and infection [28] .
To our knowledge, this represents the first publication to address surgical opioid prescription among the contemporary cohort of veterans deployed during the era of the Iraq and Afghanistan wars. Notably, the population included in this study has a significant prevalence of mental health diagnoses. In anticipating the needs of the aging veteran population, opioid use is likely to represent a persistent concern in light of prior work that has identified associations of PTSD and depression with high-dose opioid receipt and adverse outcomes among patients with long-term opioid use [16, 29] . The use of VHA EMR data also affords several methodological benefits to approaching opioid use in the postsurgical setting. In contrast to administrative claims, the VHA pharmacy data presented in this work include dispensed outpatient and inpatient prescriptions extracted directly from EMR data, providing a high degree of reliability in terms of the quantities and therapies administered. Because of these strengths, the VHA represents a premier institution for studying and instituting best practice regarding the opioid epidemic, which has not yet been applied to the study of urological sources of prescription [30] .
The contributors to surgeon prescribing behavior are complex and likely represent the influence of several factors. These include the scale of surgery performed, perception of a patient's pain requirement, adoption of relatively fixed prescribing patterns during training, and an attempt to avoid refill requests. It is possible that for most urologists, routine practice is the primary driver of the quantity of opioids prescribed after surgery, which may serve to explain the observation that patients received similar doses following ureteroscopy, ESWL, and PCNL despite differences in the scale of surgery performed. The contribution of provider-level influences is highlighted by the poor fit of our multivariable models in explaining opioid dose dispensed, where surgery type, age, sex, and psychiatric comorbidity explain a very small amount of the variation in dosing. Because prescribing patterns frequently emerge from learned behaviors, an opportunity exists to offer educational interventions aimed at reinforcing improved postoperative opioid dispensing.
There are several practical clinical contributions offered by this work. In detecting a large degree of variation across patients in surgical opioid prescription, this research highlights an opportunity for standardizing postoperative prescribing patterns for commonly performed surgeries. For example, clinicians may note that the median prescribed dose in our study was 180 MME: the equivalent of 24 tablets of 5/325-mg Percocet, or 36 tablets of 5/300-mg hydrocodone (Vicodin). Improved understanding of contemporary dispensing patterns is increasingly relevant in light of growing external scrutiny of opioid prescription. Prescription Behavior Surveillance Systems (PBSS), an initiative funded by the CDC and the Food and Drug Administration, allows public health authorities to quantify and track prescribing rates and outliers, including data from VHA pharmacies [31] . Because outliers are subject to inquiry and disciplinary action, there is a need to understand normative postsurgical prescription practices [32] .
There are limitations to this study that require discussion. First, we identified opioid recipients among patients receiving surgical treatment for kidney stone disease, a significantly smaller number of patients compared with those who received opioids for renal colic, who presumably received conservative therapy and passed a stone without intervention. In addition, while the majority of veterans receive their care centrally within the VHA, we were unable to account for opioid prescription that occurred outside of the VHA. This may have resulted in underestimation of total dose received, but nonetheless allowed for insight regarding prescribing patterns within a large centralized health system. Our data set lacks information regarding the actual quantities of opioids consumed by patients, as well as the storage and disposal practices of this cohort. Because clinical characteristics related to stone burden, stone size, and procedure length were not available in the WVCS cohort, we cannot account for the influence of these factors that may affect postoperative pain. In addition, we did not have individual provider-level data. Lastly, we excluded patients receiving long-term opioids at the time of surgery as sensitized patients experience distinct pain requirements. As a result, we are unable to evaluate the role of longterm opioid use on postoperative prescription, a clinical situation that has become increasingly common in the setting of alarmingly high national rates of long-term use.
Optimized approaches to postoperative pain are poised to play an expanding role for surgeons in light of an improved understanding of the potential harms associated with overprescription. Recognizing the degree of variation in postoperative prescription offers an opportunity for planning educational interventions that seek to minimize highdose prescription. As an additional consideration, no standards currently exist to dictate conventionally appropriate doses following urological surgery. To this end, additional research is needed to improve the precision of how pain is controlled after surgery. Dissemination of national prescription habits may seek to add clarity and would inform interventions to reinforce guideline-concordant practices that have been successfully employed in other settings. Lastly, promise is held in expanding the role of nonopioid analgesics, which may offer improved safety profiles.
Conclusions
Among a national sample of OEF/OIF/OND veterans receiving surgical treatment for kidney stones, we observed a high degree of variation in dispensed postoperative opioid dose. The dose dispensed did not vary by surgical approach; however, comorbid diagnosis of PTSD was independently associated with higher dose received. Further efforts are warranted to improve the understanding of factors influencing postoperative opioid prescribing after urologic surgery.
